D-Sight
PrivateLast Round
VC Round
Feb 23, 2026
Total Funding Raised
$1.08M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
D-Sight operates in Healthcare & Life Sciences and is based in Barcelona. Its latest recorded funding round was a VC Round in February 2026.
D-Sight is a biotechnology company developing neuroprotective eye drops for the treatment of retinal neurodegenerative diseases such as diabetic retinopathy and glaucoma.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
D-Sight Comparables
Compare D-Sight with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aspecthera Pty Ltd | 86% | |
| Exonate | 84% | |
| Glucox Biotech AB | 84% |
For institutional investors. Book with your work email.
D-Sight Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Feb 23, 2026 | ||||
| Seed | May 2, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
D-Sight Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Prous Institute for Biomedical Research | VC Round |
| Clave Capital | VC Round, Seed |
| Catalan Institute of Finance | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 23, 2026
$2.36M round led by Clave Capital.
- Feb 2, 2026
Monthly visitors grew 36% MoM, reaching 1.3K.
For institutional investors. Book with your work email.
D-Sight Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about D-Sight's valuation, stock price, and market status.
Is D-Sight a public or private company?
D-Sight is a private company.
What is the current stock price of D-Sight?
D-Sight is a private company, so its shares have no public market price. Caplight tracks D-Sight's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is D-Sight worth (valuation)?
Valuation information for D-Sight is not publicly available.
Can I buy D-Sight stock?
D-Sight shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was D-Sight's last funding round?
D-Sight's most recent funding round was VC Round on February 23, 2026.
Who are the main investors in D-Sight?
Key investors in D-Sight include Clave Capital.
Will D-Sight IPO soon?
No public IPO plans have been announced for D-Sight.
How can I track D-Sight secondary market activity?
Caplight tracks bids, offers, and trades in D-Sight's shares on secondary markets.